Question: "What is a sign of an efficient light source?" Context: "An important property of light fixtures is the luminous efficacy or wall-plug efficiency, meaning the amount of usable light emanating from the fixture per used energy, usually measured in lumen per watt. A fixture using replaceable light sources can also have its efficiency quoted as the percentage of light passed from the "bulb" to the surroundings. The more transparent the lighting fixture is, the higher efficacy. Shading the light will normally decrease efficacy but increase the directionality and the visual comfort probability." Answer:
Ans: more transparent

Question: "What was rampant during the 10th century?" Context: "In the 2nd century CE, Mahayana Sutras spread to China, and then to Korea and Japan, and were translated into Chinese. During the Indian period of Esoteric Buddhism (from the 8th century onwards), Buddhism spread from India to Tibet and Mongolia." Answer:
Ans: Buddhism

Question: "What can a canine's olfactory glands do?" Context: "Anthropologists believe the most significant benefit would have been the use of dogs' robust sense of smell to assist with the hunt. The relationship between the presence of a dog and success in the hunt is often mentioned as a primary reason for the domestication of the wolf, and a 2004 study of hunter groups with and without a dog gives quantitative support to the hypothesis that the benefits of cooperative hunting was an important factor in wolf domestication." Answer:
Ans: assist with the hunt

Question: "What does the T in "ADAPT" stand for?" Context: "Possible improvements include clarification of clinical trial regulations by FDA. Furthermore, appropriate economic incentives could persuade pharmaceutical companies to invest in this endeavor. Antibiotic Development to Advance Patient Treatment (ADAPT) Act aims to fast track the drug development to combat the growing threat of 'superbugs'. Under this Act, FDA can approve antibiotics and antifungals treating life-threatening infections based on smaller clinical trials. The CDC will monitor the use of antibiotics and the emerging resistance, and publish the data. The FDA antibiotics labeling process, 'Susceptibility Test Interpretive Criteria for Microbial Organisms' or 'breakpoints', will provide accurate data to healthcare professionals. According to Allan Coukell, senior director for health programs at The Pew Charitable Trusts, "By allowing drug developers to rely on smaller datasets, and clarifying FDA's authority to tolerate a higher level of uncertainty for these drugs when making a risk/benefit calculation, ADAPT would make the clinical trials more feasible."" Answer:
Ans: Treatment